Lupin recalls 26,352 bottles of Rifampin Capsules in US market

10 Apr 2024 Evaluate

Lupin is recalling 26,352 bottles of Rifampin Capsules (300 mg), an antibiotic medication in the US market. The affected lot has been produced by the drug firm at its Aurangabad-based facility and marketed in the American market by its Baltimore-based unit Lupin Pharmaceuticals, Inc.

As per the US Food and Drug Administration (USFDA), the company is recalling the lot for being ‘Subpotent’. The company issued the Class II recall on March 21 this year.  

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2123.90 -23.70 (-1.10%)
28-Jan-2026 13:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.10
Dr. Reddys Lab 1223.80
Cipla 1318.30
Zydus Lifesciences 889.80
Lupin 2123.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×